Natural D‐glucose as a biodegradable MRI contrast agent for detecting cancer

Modern imaging technologies such as CT, PET, SPECT, and MRI employ contrast agents to visualize the tumor microenvironment, providing information on malignancy and response to treatment. Currently, all clinical imaging agents require chemical labeling, i.e. with iodine (CT), radioisotopes (PET/SPECT), or paramagnetic metals (MRI). The goal was to explore the possibility of using simple D‐glucose as an infusable biodegradable MRI agent for cancer detection.

[1]  David C. Alsop,et al.  Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imaging , 2010, Neuroradiology.

[2]  C. Zimmer,et al.  Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. , 2003, Radiology.

[3]  T Sasaki,et al.  Perfusion Imaging of Brain Tumors Using Arterial Spin-Labeling: Correlation with Histopathologic Vascular Density , 2008, American Journal of Neuroradiology.

[4]  E Terreno,et al.  Advances in metal-based probes for MR molecular imaging applications. , 2010, Current medicinal chemistry.

[5]  R. Lenkinski,et al.  CEST and PARACEST MR contrast agents , 2010, Acta radiologica.

[6]  Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice. , 2011, Nuclear medicine and biology.

[7]  E. Lozner,et al.  THE INTRAVENOUS GLUCOSE TOLERANCE TEST. , 1941, The Journal of clinical investigation.

[8]  P. V. van Diest,et al.  Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  S. Gambhir.  Molecular imaging of cancer with positron emission tomography , 2002, Nature Reviews Cancer.

[10]  S. Polak‐Charcon,et al.  Glucose transporters and transport kinetics in retinoic acid-differentiated T47D human breast cancer cells. , 2000, American journal of physiology. Endocrinology and metabolism.

[11]  Makoto Kojima,et al.  MR perfusion imaging using the arterial spin labeling technique for breast cancer , 2012, Journal of magnetic resonance imaging : JMRI.

[12]  Jinyuan Zhou,et al.  Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging , 2008, Magnetic resonance in medicine.

[13]  S. Gottschalk,et al.  Imatinib (STI571)-Mediated Changes in Glucose Metabolism in Human Leukemia BCR-ABL-Positive Cells , 2004, Clinical Cancer Research.

[14]  Jinyuan Zhou,et al.  Quantitative description of proton exchange processes between water and endogenous and exogenous agents for WEX, CEST, and APT experiments , 2004, Magnetic resonance in medicine.

[15]  J. Bulte,et al.  New “multicolor” polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI , 2008, Magnetic resonance in medicine.

[16]  A Dean Sherry,et al.  Paramagnetic lanthanide complexes as PARACEST agents for medical imaging. , 2006, Chemical Society reviews.

[17]  F. Howe,et al.  Why are cancers acidic? A carrier-mediated diffusion model for H+ transport in the interstitial fluid. , 2001, Novartis Foundation symposium.

[18]  P. Gullino,et al.  Glucose consumption by transplanted tumors in vivo. , 1967, Cancer research.

[19]  H. Degani,et al.  Glycolysis as a metabolic marker in orthotopic breast cancer, monitored by in vivo (13)C MRS. , 2002, American journal of physiology. Endocrinology and metabolism.

[20]  Jinyuan Zhou,et al.  Chemical exchange saturation transfer imaging and spectroscopy , 2006 .

[21]  Kevin Brindle,et al.  New approaches for imaging tumour responses to treatment , 2008, Nature Reviews Cancer.

[22]  John A. Detre,et al.  Clinical neuroimaging using arterial spin-labeled perfusion magnetic resonance imaging , 2007, Neurotherapeutics.

[23]  J. Best,et al.  Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer , 2005, Journal of cellular physiology.

[24]  Robert J. Gillies,et al.  Tumor pH and Its Measurement , 2010, The Journal of Nuclear Medicine.

[25]  M. Hendrix,et al.  Role for glucose transporter 1 protein in human breast cancer , 2008, Pathology & Oncology Research.

[26]  Thomas E Yankeelov,et al.  Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. , 2007, Magnetic resonance imaging.

[27]  D Artemov,et al.  Two‐compartment model for determination of glycolytic rates of solid tumors by in vivo 13C NMR spectroscopy , 1998, NMR in biomedicine.

[28]  Jinyuan Zhou,et al.  In vivo three‐dimensional whole‐brain pulsed steady‐state chemical exchange saturation transfer at 7 T , 2012, Magnetic resonance in medicine.

[29]  P. Zijl,et al.  Imaging of glucose uptake in breast tumors using non-labeled D-glucose , 2010 .

[30]  Jinyuan Zhou,et al.  Quantifying exchange rates in chemical exchange saturation transfer agents using the saturation time and saturation power dependencies of the magnetization transfer effect on the magnetic resonance imaging signal (QUEST and QUESP): Ph calibration for poly‐L‐lysine and a starburst dendrimer , 2006, Magnetic resonance in medicine.

[31]  P. Vaupel,et al.  Glucose uptake, lactate release, ketone body turnover, metabolic micromilieu, and pH distributions in human breast cancer xenografts in nude rats. , 1988, Cancer research.

[32]  Paul J. van Diest,et al.  Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography , 2002 .

[33]  David C. Zhu,et al.  Breast tissue differentiation using arterial spin tagging , 2003, Magnetic resonance in medicine.

[34]  M. Lythgoe,et al.  Assessment of tumour glucose uptake using gluco-CEST , 2010 .

[35]  I. Silver,et al.  Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism , 1997, Clinical & Experimental Metastasis.

[36]  M. Bryś,et al.  Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast Cancers , 2012, Pathology & Oncology Research.

[37]  F. Gallagher,et al.  Hyperpolarized 13C MRI and PET: In Vivo Tumor Biochemistry , 2011, The Journal of Nuclear Medicine.

[38]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[39]  Nirbhay N. Yadav,et al.  Chemical exchange saturation transfer (CEST): What is in a name and what isn't? , 2011, Magnetic resonance in medicine.

[40]  Robert J Gillies,et al.  Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors. , 2003, Neoplasia.

[41]  Gil Navon,et al.  Assessment of glycosaminoglycan concentration in vivo by chemical exchange-dependent saturation transfer (gagCEST) , 2008, Proceedings of the National Academy of Sciences.

[42]  Mark D Pagel,et al.  Using two chemical exchange saturation transfer magnetic resonance imaging contrast agents for molecular imaging studies. , 2009, Accounts of chemical research.

[43]  Jinyuan Zhou,et al.  Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI , 2003, Nature Medicine.

[44]  Tristan Barrett,et al.  MRI of tumor angiogenesis , 2007, Journal of magnetic resonance imaging : JMRI.

[45]  Robert J. Gillies,et al.  A microenvironmental model of carcinogenesis , 2008, Nature Reviews Cancer.

[46]  John A. Detre,et al.  Magnetic Resonance Imaging of Glutamate , 2011, Nature Medicine.

[47]  Jinyuan Zhou,et al.  Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain , 2010, Magnetic resonance in medicine.

[48]  J. Bulte,et al.  Sensitive NMR detection of cationic-polymer-based gene delivery systems using saturation transfer via proton exchange. , 2001, Journal of the American Chemical Society.

[49]  P. Varlet,et al.  Pulsed arterial spin labeling applications in brain tumors: practical review. , 2008, Journal of neuroradiology. Journal de neuroradiologie.

[50]  Bennett A Landman,et al.  Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments , 2009, Magnetic resonance in medicine.

[51]  D Artemov,et al.  Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. , 2001, Neoplasia.

[52]  R S Balaban,et al.  A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). , 2000, Journal of magnetic resonance.

[53]  Peter C M van Zijl,et al.  MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST) , 2007, Proceedings of the National Academy of Sciences.

[54]  Jinyuan Zhou,et al.  Amide proton transfer (APT) contrast for imaging of brain tumors , 2003, Magnetic resonance in medicine.

[55]  S. Y. Kim,et al.  Diagnostic accuracy and interobserver variability of pulsed arterial spin labeling for glioma grading , 2008, Acta radiologica.

[56]  Wei Huang,et al.  Dynamic NMR effects in breast cancer dynamic-contrast-enhanced MRI , 2008, Proceedings of the National Academy of Sciences.

[57]  K. Hossmann,et al.  Local Cerebral Blood Flow and Glucose Consumption of Rats with Experimental Gliomas , 1982, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.